CorMedix CRMD Ratios & Valuation
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 91.9%— | 92.9%— | 94.4%— | —— | —— | |
| Free cash flow margin | 48.7%— | 55.4%— | 34.7%— | —— | —— | |
| Efficiency | ||||||
| Asset turnover | 0.8×— | 0.7×— | 0.5×— | —— | —— | |
| Inventory turnover | 1.7×— | 1.2×— | 0.7×— | —— | —— | |
| Liquidity | ||||||
| Current ratio | 3×-1.2× | 2.1×-1.3× | 1.9×-2.0× | 7.8×+3.0× | 4.2×-2.4× | |
| Quick ratio | 2.7×-1.3× | 1.9×-1.2× | 1.7×-1.9× | 7.5×+3.1× | 4×-2.4× | |
| Cash ratio | 1.4×-0.5× | 0.8×-0.4× | 0.4×-1.5× | 5×+2.4× | 1.9×-1.8× | |
| Per Share | ||||||
| Book value per share | $4.70+182% | $5.05+251% | $4.34+335% | $3.07+283% | $1.67+65.1% | |
| Valuation | ||||||
| Market capitalization | $605.65M-34.4% | $916.32M+86.4% | $868.17M+92.3% | $1.07B+348% | $401.52M+72.2% | |
| Price / sales | 1.5×-9.6× | 2.9×— | 4.1×— | —— | —— | |
| Price / book | 1.4×-6.6× | 2.3×-3.5× | 2.3×-5.4× | 4.8×-0.3× | 3.5×-0.5× | |
| Free cash flow yield | 32.1%+33.6pp | 18.9%+29.2pp | 8.6%+21.0pp | 2.9%+24.4pp | -3.4%+16.2pp |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are CorMedix's profit margins?
- CorMedix (CRMD) runs a 91.9% gross margin and a 48.4% operating margin, with a 45.2% net margin.
- Where do CorMedix's ratios come from?
- Every ratio is computed from CorMedix's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
